NEW YORK–(BUSINESS WIRE)–Iveric Bio announced that Pravin U. Dugel, M.D., President, will participate in a panel at the Wedbush Conference on Wed., Aug. 11 at 8:00 a.m. ET.
Author: Business Wire
STAAR Surgical Reports Record Second Quarter Net Sales of $62.4 Million Up 77% Y/Y and Increases Outlook for 2021
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended …
Eyevensys Raises $12M in a Series B Plus Funding Round
PARIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)– #Eyevensys–Eyevensys, a private biotech developing gene therapies for ophthalmic diseases, today announces it has raised $12M in a Series B Plus funding round.
RightEye Launches Eye Care’s First Automated Sensorimotor Exam for Binocular Vision Testing
BETHESDA, Md.–(BUSINESS WIRE)–RightEye LLC, an advanced eye-tracking technology company, has launched the world’s first automated, quantitative sensorimotor exam system. RightEye Sensorimotor is an easy-to-use, all-in-one examination system that opto…
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ADX-2191 (methotrexate for intravitreal injection) for the t…
Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–Iveric Bio announced financial and operating results for the quarter ended June 30, 2021 and provided a general business update.
Topcon Healthcare to Partner with RetInSight
OAKLAND, N.J.–(BUSINESS WIRE)– #TopconHealthcare–Topcon Healthcare of Oakland, NJ, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will partner with RetInSight GmbH, a developer…
Worldwide Corneal Implants Industry to 2026 – North America Accounted for the Largest Share in the Global Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Corneal Implants Market- Growth, Trends, COVID-19 Impact and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering. The corneal implants market is projected to register a CAGR of more than 6% …
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and Chief Executive Officer Todd C. Brady, M.D., Ph.D. will participate in analyst-led fireside conversations at the BTIG Virtual Biot…
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–Iveric Bio granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to five newly hired employees.
Retinal Detachment Market Insights, Competitive Landscape and Market Forecast Report 2021-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Detachment – Market Insights, Competitive Landscape and Market Forecast – 2026” drug pipelines has been added to ResearchAndMarkets.com’s offering. This ‘Retinal Detachment – Market Insights, Competitive Landscape …
Oscar Wylee Announces 100th Store; Further Expansion Planned
SYDNEY–(BUSINESS WIRE)– #100thStore–Oscar Wylee has announced the opening of its 100th retail store in Albany – New Zealand, with trading to commence from 9th August 2021. This comes on the back of the eyewear retailer opening 27 new stores across A…
Advanced Clinical’s Graham Belgrave Named to the 2021 PharmaVOICE 100 List of Distinguished Leaders
DEERFIELD, Ill.–(BUSINESS WIRE)–Graham Belgrave, SVP of European Operations at Advanced Clinical, has been recognized as a distinguished leader on the 2021 PharmaVOICE 100 list.
Fabrinet to Announce Fourth Quarter and Fiscal-Year 2021 Financial Results on August 16, 2021
BANGKOK–(BUSINESS WIRE)– #EarningsDate–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, tod…
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Second-Quarter 2021 Financial Results and Discuss Recent Business Highlights
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, August 5, 2021 to report financial results for the quarter ended June 30, 2021 and discuss recent business high…
Ocular Therapeutix™ Announces First Patient Dosed in U.S.-based Phase 1 Clinical Trial of OTX-TKI for the Treatment of Wet Age-Related Macular Degeneration
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s sec…
National Vision Holdings, Inc. Announces Second Quarter 2021 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2021 financial results before the market opens on Thursday, August 12, 2021. The Company will host a conferen…
Global Graves' Ophthalmopathy Disease Clinical Trials Review: H1, 2021 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Graves’ Ophthalmopathy Disease – Global Clinical Trials Review, H1, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This report provides an overview of Graves’ Ophthalmopathy Clinical trials scen…
FDA Accepts Application for Genentech’s Faricimab for the Treatment of Wet Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Pr…